A first-in-human clinical trial of RXC-004
Phase of Trial: Phase I
Latest Information Update: 12 Sep 2017
At a glance
- Drugs RXC 004 (Primary)
- Indications Cancer; Gastric cancer
- Focus Adverse reactions; First in man
- 12 Sep 2017 Trial design of the study presented at the 42nd European Society for Medical Oncology Congress.
- 02 Sep 2017 New trial record
- 31 Aug 2017 According to a Redx Pharma media release, the company will present a poster on this planned trial at the European Society for Medical Oncology (ESMO) Annual Meeting 2017.